Guidance for Industry: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components (including Source Plasma and Source Leukocytes) to Adequately and Appropriately Reduce the Risk of Transmission of HIV-1 and HCV, CBER, Biologics
via Whats New Vaccines Blood Biologics RSS Feed http://bit.ly/2IMv9TQ
No comments:
Post a Comment